| |
PRODUCT NAME |
ORDER |
 |
4-(METHANESULFONYL)PHENYLBORONIC ACID, PINACOL ESTER |
 |
 |
Carbamic acid, [1-(hydroxymethyl)-2-methyl-2-propenyl]-, 1,1-dimethylethyl |
 |
 |
4H-1-Benzopyran-4-one,2-[3-(dimethylamino)phenyl]-(9CI) |
 |
 |
Carbamic acid, (5-cyano-2-furanyl)-, 1,1-dimethylethyl ester (9CI) |
 |
 |
Benzenemethanol, 4-ethyl-alpha-ethynyl-, acetate, (alphaR)- (9CI) |
 |
 |
Benzenemethanol, alpha-ethynyl-4-(1-methylethyl)-, (alphaS)- (9CI) |
 |
 |
1,4-Dioxaspiro[4.4]nonane-7,8-dione |
 |
 |
1,2-Cyclopentanedione,4,4-bis(methylthio)-(9CI) |
 |
 |
2,6-DINITROBENZOIC ACID |
 |
 |
4-METHOXYCARBONYL-3-METHOXYPHENYLBORONIC ACID |
 |
 |
3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID, PINACOL ESTER |
 |
 |
Propanoic acid, 2-methyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester (9CI) |
 |
 |
Propanoic acid, 2-methyl-, 1-azabicyclo[2.2.2]oct-3-yl ester (9CI) |
 |
 |
2(3H)-Benzofuranone, 3a,7a-dihydro-3a-hydroxy- (9CI) |
 |
 |
Carbamic acid, [3-[(4-chlorophenyl)methyl]-3,4-dihydro-4-oxo-2-propyl-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI) |
 |
 |
Carbamic acid, [3-[(4-chlorophenyl)methyl]-3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI) |
 |
 |
1,1-Biphenyl,2,6-dimethoxy-4-methyl-(9CI) |
 |
 |
3-Nitrophthalic acid |
 |
 |
Benzenemethanol, 2-(1-methyl-1-propenyl)- (9CI) |
 |
 |
Cyclopropanecarbonyl chloride, 3-(2-chloro-1-propenyl)-2,2-dimethyl- (9CI) |
 |
 |
Cyclopropanecarbonyl chloride, 3-(2-chloroethenyl)-2,2-dimethyl- (9CI) |
 |
 |
2-Amino-4-fluoro-5-[(1-methyl-1H-imidazol-2-yl)thio]-N-thiazol-2-ylbenzamide |
 |
 |
Tyrosine, 2-ethyl-O-methyl- (9CI) |
 |
 |
Phenylalanine, 4-ethyl-2-methoxy- (9CI) |
 |
 |
Phenylalanine, 5-ethyl-2-methoxy- (9CI) |
 |
 |
Phenylalanine, 2-ethoxy- (9CI) |
 |
 |
Pyrazolo[1,5-a]pyrimidin-7-ol, 2-(2-chlorophenyl)-5-phenyl- (9CI) |
 |
 |
Thiourea, N-(3-chlorophenyl)-N-[4-(4-chlorophenyl)-5-methyl-1H-pyrazol-3-yl]- (9CI) |
 |
 |
Pyrazolo[1,5-a]pyrimidine-2-carboxamide, N-(2,5-dimethylphenyl)-5-(1-methylethyl)-7-(trifluoromethyl)- (9CI) |
 |
 |
2(1H)-Isoquinolineaceticacid,3,4-dihydro-alpha-oxo-(9CI) |
 |
 |
Carbamic acid, [2-butyl-5-methyl-3-[[3-(trifluoromethyl)phenyl]methyl]-3H-imidazo[4,5-b]pyridin-6-yl]-, 1,1-dimethylethyl ester (9CI) |
 |
 |
Carbamic acid, [2-butyl-5-methyl-3-[[4-(trifluoromethyl)phenyl]methyl]-3H-imidazo[4,5-b]pyridin-6-yl]-, 1,1-dimethylethyl ester (9CI) |
 |
 |
3-Pyridinecarboxamide,6-chloro-N-[(tetrahydro-2-furanyl)methyl]-(9CI) |
 |
 |
3-Pyridinecarboxamide,6-chloro-N-cyclohexyl-(9CI) |
 |
 |
Acetamide, N-methyl-2-[(3-methyl-3H-imidazo[4,5-b]pyridin-2-yl)thio]- (9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[3-(1H-benzimidazol-2-yl)propyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[2-[(1,1-dioxido-1,2-benzisothiazol-3-yl)amino]ethyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[2-[(4-morpholinylacetyl)amino]phenyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[2-(1-pyrrolidinylcarbonyl)phenyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[4-[(2-pyridinylcarbonyl)amino]phenyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[2-[(2-pyridinylcarbonyl)amino]phenyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[3-oxo-3-(10H-phenothiazin-10-yl)propyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[4-oxo-4-(10H-phenothiazin-10-yl)butyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[2-(1-piperidinyl)phenyl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[3-(phenylmethyl)-1H-1,2,4-triazol-5-yl]-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-(5,5-dioxido-6H-dibenzo[c,e][1,2]thiazin-9-yl)-(9CI) |
 |
 |
6-Quinoxalinecarboxamide,N-[1-(4-methoxyphenyl)ethyl]-(9CI) |
 |
 |
1H-Pyrazole-4-carboxamide,N-[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]-1,3-diphenyl-(9CI) |
 |
 |
1H-Pyrazole-4-carboxamide,1,3-diphenyl-N-(tetrahydro-1,1-dioxido-3-thienyl)-(9CI) |
 |
 |
1H-Thieno[2,3-c]pyrazole-5-carboxamide,N-[7-(acetylamino)-2,3-dihydro-1,4-benzodioxin-6-yl]-3-methyl-1-phenyl-(9CI) |
 |